Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

6.07
Delayed Data
As of Aug 03
 -0.04 / -0.65%
Today’s Change
3.33
Today|||52-Week Range
6.85
+45.56%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close6.11
Today’s open6.10
Day’s range5.98 - 6.33
Volume317,509
Average volume (3 months)455,479
Market cap$368.9M
Dividend yield--
Data as of 3:59pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-116.66%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+31.00%
P/E ratio1,302.3
Price/Sales2.68
Price/Book6.09

Competitors

 Today’s
change
Today’s
% change
GNMKGenMark Diagnostics ...-0.46-5.41%
CTICCTi Biopharma Corp-0.01-0.54%
NVTAInvitae Corp-0.08-0.80%
RDNTRadNet Inc+0.15+2.24%
Data as of 4:00pm ET, 08/03/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$0.00
Annual revenue (last year)$87.1M
Annual profit (last year)$1.1M
Net profit margin1.30%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. VanOort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts